Bahl & Gaynor Inc Abbott Laboratories Transaction History

Bahl & Gaynor Inc

$17.9 Billion
Q1 2024

A detailed history of Bahl & Gaynor Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Bahl & Gaynor Inc holds 1,803,326 shares of ABT stock, worth $186 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares

1,803,326

Previous 1,809,287 0.33%

Holding current value

$186 Million

Previous $199 Million 2.92%

% of portfolio

1.14%

Previous 1.2%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $652,848 - $721,042	-5,961 Reduced 0.33%	1,803,326 $205 Million
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $23.5 Million - $28.7 Million	-260,061 Reduced 12.57%	1,809,287 $199 Million
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $41.4 Million - $49.6 Million	-433,068 Reduced 17.31%	2,069,348 $200 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $25 Million - $27.9 Million	-248,402 Reduced 9.03%	2,502,416 $273 Million
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $20.6 Million - $24.2 Million	212,463 Added 8.37%	2,750,818 $279 Million

Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $21.6 Million - $25.4 Million	-227,509 Reduced 8.23%	2,538,355 $279 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $15.7 Million - $18.2 Million	162,303 Added 6.23%	2,765,864 $268 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $61.3 Million - $74.1 Million	600,614 Added 29.99%	2,603,561 $283 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $68.3 Million - $83.2 Million	-598,708 Reduced 23.01%	2,002,947 $237 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $8.95 Million - $11 Million	-77,480 Reduced 2.89%	2,601,655 $366 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $772,289 - $854,377	-6,620 Reduced 0.25%	2,679,135 $316 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $341,066 - $401,484	3,224 Added 0.12%	2,685,755 $311 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $6.48 Million - $7.64 Million	-59,574 Reduced 2.17%	2,682,531 $321 Million
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $7.79 Million - $8.49 Million	-74,172 Reduced 2.63%	2,742,105 $300 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $2.92 Million - $3.54 Million	-31,840 Reduced 1.12%	2,816,277 $306 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $494,795 - $633,276	-6,462 Reduced 0.23%	2,848,117 $260 Million
Q1 2020 May 26, 2020	BUY	$62.82 - $91.86 $129 Million - $189 Million	2,053,747 Added 256.45%	2,854,579 $225 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $144 Million - $211 Million	-2,291,613 Reduced 74.1%	800,832 $63.2 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $905,141 - $1.01 Million	11,529 Added 0.37%	3,092,445 $269 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $4.25 Million - $4.61 Million	51,894 Added 1.71%	3,080,916 $258 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $5.49 Million - $6.4 Million	75,313 Added 2.55%	3,029,022 $255 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $22.2 Million - $26.8 Million	-334,671 Reduced 10.18%	2,953,709 $236 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $56.4 Million - $63.9 Million	859,950 Added 35.41%	3,288,380 $238 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $53.7 Million - $64.7 Million	-882,588 Reduced 26.66%	2,428,430 $178 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $8.45 Million - $9.32 Million	146,702 Added 4.64%	3,311,018 $202 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $10.6 Million - $12 Million	-188,663 Reduced 5.63%	3,164,316 $190 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $3.52 Million - $3.77 Million	-65,563 Reduced 1.92%	3,352,979 $191 Million
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $16.8 Million - $18.8 Million	-350,480 Reduced 9.3%	3,418,542 $182 Million
Q2 2017 Aug 11, 2017	BUY	N/A	68,596 Added 1.85%	3,769,022 $183 Million
Q2 2017 Aug 10, 2017	BUY	N/A	3,700,426	3,700,426 $142 Million

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account